Sientra acquires OPUS breast implant manufacturing operation from Lubrizol

Sientra acquired the dedicated FDA-approved silicone breast implant manufacturing operation in Franklin, Wisconsin from Lubrizol Life Science, including a turnkey facility in commercial scale-up.

“This acquisition advances our strategic goal of becoming the leading provider of breast products in the worldwide breast augmentation and reconstruction market.”biospace.com

• 1 source
• biospace.comSientra Announces Acquisition of the Independently Operated OPUS® Breast Implant Manufacturing Operation from Lubrizol Life Science - BioSpaceGabrielle MassonNov 7, 2019

Summarized from public sources; check the original articles before acting on it.